Zivo Bioscience (ZIVO) is scheduled to report Q4 earnings on May 22, 2026. Analysts estimate EPS of $-0.29 and quarterly revenue of $94.00K.
In the most recent quarter (Q3), Zivo Bioscience reported EPS of $-0.27, beating estimates of $-0.36 by 0.25%. Revenue came in at $65.63K, missing the estimate of $428.00K by 0.85%.
Over the last 4 quarters, Zivo Bioscience has averaged an EPS surprise of 0.27% and a revenue surprise of 0.60%.
Analyze the earnings history of Zivo Bioscience using advanced sorting and filters.
The chart below shows Zivo Bioscience's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Zivo Bioscience's reported revenue compared to analyst estimates over recent quarters.
Zivo Bioscience (ZIVO) is scheduled to report earnings on May 22, 2026. The last reported earnings were for reported on November 14, 2025 for Q3.
The Actual EPS was $-0.27, which beat the estimate of $-0.36.
The Actual Revenue was $65.63K, which missed the estimate of $428.00K.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-14 | $-0.27 | $-0.36 | 25.0 % |
| Q4 | 2025-03-18 | $-0.36 | $-0.36 | 0.00 % |
| Q3 | 2024-11-14 | $-0.67 | $-0.39 | -71.8 % |
| Q1 | 2023-05-10 | $-1.26 | $-1.44 | 12.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-14 | $65.63K | $428.00K | -84.7 % |
| Q2 | 2025-08-14 | $53.40K | $150.00K | -64.4 % |
| Q4 | 2025-03-18 | $90.00K | $150.00K | -40.0 % |
| Q3 | 2024-11-14 | $31.50K | $70.00K | -55.0 % |